FilingIndex
DEF 14AThe Ballot

Theriva Biologics, Inc. files DEF 14A

Filed Aug 14, 2018 · 7y ago · Accession 0001144204-18-044161

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
TOVX
CIK
894158
Form type
DEF 14A
Filing date
Aug 14, 2018
Report date
Sep 24, 2018
Document
tv499955-def14a.htm
Size
698 KB